Description:
The International Journal of Pharmacology and Pharmaceutical Technology (IJPPT) publishes research articles in the fields of pharmacology and pharmaceutical technology. The journal publishes innovative research on advances in drug discovery technologies, formulation technology, biopharmaceuticals... Show More
The International Journal of Pharmacology and Pharmaceutical Technology (IJPPT) publishes research articles in the fields of pharmacology and pharmaceutical technology. The journal publishes innovative research on advances in drug discovery technologies, formulation technology, biopharmaceuticals, and related fields. The journal also provides a platform for communicating the latest technological advances and techniques in pharmacology and pharmaceutical technology to industrial and academic professionals.
Mission & Scope:
The mission of the International Journal of Pharmacology and Pharmaceutical Technology (IJPPT) is to provide a forum for innovative research and technologies and the application of scientific knowledge in the fields of pharmacology and pharmaceutical technology. The journal encourages the growth of educational, scientific, and industrial research activities among scientists and academicians in... Show More
The mission of the International Journal of Pharmacology and Pharmaceutical Technology (IJPPT) is to provide a forum for innovative research and technologies and the application of scientific knowledge in the fields of pharmacology and pharmaceutical technology. The journal encourages the growth of educational, scientific, and industrial research activities among scientists and academicians in the fields of pharmacology and pharmaceutical sciences, as well as medical sciences. To fulfill this mission, the journal provides a depth of knowledge on the latest advances in these fields to researchers and academicians.
Coverage:
- Bioavailability and bioequivalence studies
- Biochemical Pharmacology
- Clinical pharmacokinetics
- Clinical toxicology
- Clinical Trials
- dvances in novel drug delivery systems
- Endocrine pharmacology
- Gene targeted drug delivery systems
- Immuno-pharmacology
- Mechanism of drug toxicity
- Molecular pharmacology
- Monoclonal antibodies
- Novel formulation techniques
- Novel vaccine delivery systems
- Nucleic-acid therapeutics
- Peptide drug delivery system
- Pharmacogenetics
- Pharmacogenomics
- Pharmacovigilance
- Prediction and avoidance of drug interaction
- Protein and peptide therapeutics
- Receptor pharmacology
- Stem cell therapy
- Toxicokinetics
- Vaccines production technology
IGI Global holds its journals to the highest ethical practices.
View Full Editorial PolicyAs this journal is under the Hybrid Open Access model, authors can choose between Standard (Non-OA) publishing or Open Access publishing. Find the policies for the publishing models below:
- Standard (Non-OA) Publishing: If the author chooses to publish under the Standard (Non-OA) model, the article will be published under a Green OA model and the copyright of
their article will transfer to IGI Global under our Author Warranty and Transfer of Copyright Agreement.
However, through Green OA, IGI Global supports a Fair Use Policy, enabling authors to Post the final
typeset PDF (which includes the title page, table of contents and other front materials, and the copyright
statement) of their chapter or article (NOT THE ENTIRE BOOK OR JOURNAL ISSUE), on the author or
editor's secure personal website and/or their university repository site. See the Fair Use Policy for sharing allowances conducive to Green Open Access.
- Open Access Publishing: If the author choses to publish under OA, the authors receive the
Creative Commons Attribution 4.0 International (CC BY 4.0) licensing arrangement. The copyright for the
work remains solely with the author(s) of the article. Others may distribute, remix, tweak, and build upon
the work, even commercially, without asking prior permission from the publisher or author and so long as
they credit the author for the original creation. All authors are required to sign an author's warranty
stating that the materials are original and unpublished elsewhere. The journal will not publish any
material that has been previously published elsewhere. Learn More
This journal operates under the Hybrid Open Access model,
allowing the author to choose between traditional, subscription-based publishing, or Open Access publishing.
Subscription-Based Publishing/Green Open Access:
Article manuscripts require no Article Processing Charge (APC) and require authors to transfer the copyright of the
manuscript to IGI Global. Manuscripts are published behind a paywall and must be purchased for use. See the
Fair Use Policy
for sharing allowances conducive to Green Open Access.
Open Access Publishing:
Article manuscripts receive the Creative Commons Attribution 4.0 International
(CC BY 4.0) licensing arrangement. The copyright for the work remains solely with the author(s) of
the article. Others may distribute, remix, tweak, and build upon the work, even commercially, without asking
prior permission from the publisher or author and so long as they credit the author for the original creation.
A one-time Article Processing Charge (APC) of US $2,300 must be paid AFTER the manuscript has gone
through the full double-blind peer review process and the Editor(s)-in-Chief at his/her/their full discretion
has decided to accept the manuscript based on the results of the double-blind peer review process. Learn
more about APCs
here.
Open Access Funding:
IGI Global recognizes that many researchers may not know where to begin when searching for OA funding opportunities. IGI Global recently
launched an
Open Access Funding Resources
page for researchers to browse. This page provides a comprehensive list of OA funding sources available for researchers to secure funds
for their various OA publications.
Editorial Office
701 E. Chocolate Ave.
Hershey, PA 17033, USA
717-533-8845 x100